Skip to main content
OpenTrials

Clinical trial condition

Epithelial Ovarian Cancer

Explore clinical trials studying Epithelial Ovarian Cancer. Study availability and eligibility vary by location and protocol.

142 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Epithelial Ovarian Cancer trial results

Completed

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

NCT02915523

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • H. Lee Moffitt Cancer Center and Research Tampa, Florida, United States
  • Florida Cancer Specialist East Region (SCRI Affiliate) West Palm Beach, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Greater Baltimore Medical Center Baltimore, Maryland, United States
View Trial Details
Completed

Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation

NCT02477202

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial

NCT01506856

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • Queen Mary Hospital Hong Kong, High West
  • Aichi Cancer Center Hospital Chikusa, Aichi-ken, Japan
  • Hirosaki University School of Medicine & Hospital Hirosaki-shi, Aomori, Japan
View all 62 locations
View Trial Details
Completed

A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

NCT01891344

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Saint Jude Heritage Medical Center Fullerton, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 75 locations
View Trial Details
Completed

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

NCT02855944

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Augusta University Augusta, Georgia, United States
  • Hospital Haroldo Juacaba Instituto do Cancer do Ceara Fortaleza, Ceará, Brazil
  • Instituto de Oncologia do Parana (IOP) Curitiba, Paraná, Brazil
View all 77 locations
View Trial Details
Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details
Completed

A Study of Long-Term Responders on Olaparib

NCT02489058

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • South Eastern Sydney Local Health District Randwick, New South Wales, Australia
  • British Columbia Cancer Centre Vancouver, British Columbia, Canada
  • Ottawa Hospital Research Institute Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details

Related conditions